
September 2013 Oncology


Oral antineoplastics have advantages, but patient adherence is a concern.

Gilotrif (afatinib) is FDA approved for treating certain non-small cell lung cancers.

Why are computerized drug-drug interaction alerts usually ignored?




Pharmacists are in a pivotal position to help patients select and properly use at-home test and monitor kits.

The nutritional supplements glucosamine and chondroitin have demonstrated some potential for reducing pain associated with osteoarthritis




Federal rules are very specific.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Grants Accelerated Approval to Neladalkib for Previously Treated ALK-Positive NSCLC
2
Giredestrant Plus Everolimus Wins FDA Approval in ESR1-Mutated Advanced Breast Cancer
3
FDA Approves Secukinumab as First IL-17 Biologic for Polymyalgia Rheumatica
4
Adrabetadex Becomes First Therapy Shown to Extend Survival in Infantile-Onset Niemann-Pick Disease Type C
5